Acular (ketorolac tromethamine ophthalmic solution) 0.5%
Company: Allergan
Approval Status: Approved January 1997
Treatment for: Treatment for postoperative inflammation in patients who have undergone cataract extraction
Areas: Ophthalmology
Possible similar drugs: Acular
General Information
Other Useful Resources
Acular has been approved for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Medical Dictionary Searches
